Association of metformin and statin medications with surrogate measures of cardiovascular disease in youth with type 1 diabetes: the SEARCH for diabetes in youth study
10.6065/apem.2019.24.3.187
- Author:
Evgenia GOURGARI
1
;
Jeanette M STAFFORD
;
Ralph D'AGOSTINO
;
Lawrence M DOLAN
;
Jean M LAWRENCE
;
Amy MOTTL
;
Catherine PIHOKER
;
Elaine M URBINA
;
R Paul WADWA
;
Dana DABELEA
Author Information
1. Division of Pediatric Endocrinology, Department of Pediatrics, Georgetown University, Washington, DC, USA. eg685@georgetown.edu
- Publication Type:Original Article
- Keywords:
Metformin;
Type 1 diabetes;
Adolescents;
Statin;
Cardiovascular disease
- MeSH:
Adolescent;
Cardiovascular Diseases;
Diabetes Mellitus, Type 1;
Heart Rate;
Humans;
Hydroxymethylglutaryl-CoA Reductase Inhibitors;
Insulin;
Metformin;
Morinda;
Observational Study;
Prospective Studies;
Pulse Wave Analysis;
Vascular Stiffness
- From:Annals of Pediatric Endocrinology & Metabolism
2019;24(3):187-194
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Youth with type 1 diabetes mellitus (T1DM) are at risk of cardiovascular disease (CVD). We evaluated if metformin or statin use was associated with surrogate measures of improved CVD. METHODS: We included participants from the SEARCH observational study. Participants treated with insulin plus metformin (n=42) or insulin plus statin (n=39) were matched with 84 and 78 participants, respectively, treated with insulin alone. Measures of arterial stiffness obtained were pulse wave velocity (PWV), augmentation index (AI75), and heart rate variability as standard deviation of the normal-to-normal interval (SDNN) and root mean square differences of successive NN intervals (RMSSD).
